HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.

Moison C, Spinella JF, Chagraoui J, Lavallée VP, Lehnertz B, Thiollier C, Boivin I, Mayotte N, MacRae T, Marinier A, Hébert J, Sauvageau G.

Open source

DOI: 10.1182/bloodadvances.2021005828
Published: 2022-08-01
Container: Blood Adv
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2021005828,
  title = {HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.},
  author = {Moison C and  Spinella JF and  Chagraoui J and  Lavallée VP and  Lehnertz B and  Thiollier C and  Boivin I and  Mayotte N and  MacRae T and  Marinier A and  Hébert J and  Sauvageau G.},
  year = {2022},
  journal = {Blood Adv},
  doi = {10.1182/bloodadvances.2021005828},
  url = {https://doi.org/10.1182/bloodadvances.2021005828}
}

RIS

TY  - JOUR
TI  - HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.
AU  - Moison C
AU  -  Spinella JF
AU  -  Chagraoui J
AU  -  Lavallée VP
AU  -  Lehnertz B
AU  -  Thiollier C
AU  -  Boivin I
AU  -  Mayotte N
AU  -  MacRae T
AU  -  Marinier A
AU  -  Hébert J
AU  -  Sauvageau G.
PY  - 2022
JO  - Blood Adv
DO  - 10.1182/bloodadvances.2021005828
UR  - https://doi.org/10.1182/bloodadvances.2021005828
ER  -

APA

C, M., JF, S., J, C., VP, L., B, L., C, T., I, B., N, M., T, M., A, M., J, H., & G., S. (2022). HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.. Blood Adv. https://doi.org/10.1182/bloodadvances.2021005828

Source records

europe-pmc · retrieved 2026-09-27T06:11:03.976Z